Quantitative Analysis of Pancreatic Fat in Children with Obesity Using Magnetic Resonance Imaging and Ultrasonography
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The aim of this study was to evaluate the pancreatic fat fraction (PFF) using magnetic resonance imaging (MRI) in children with and without obesity and to correlate PFF with body mass index (BMI) z-score, hepatic fat fraction (HFF), and ultrasonography-derived pancreato-perihepatic fat index (PPHFI). Methods: This prospective study included 45 children with obesity and 19 without obesity (control group). PFF and HFF were quantitatively assessed using the abdominal multi-echo Dixon method for MRI. The PPHFI was assessed using transabdominal ultrasonography. Anthropometric, MRI, and ultrasonographic characteristics were compared between the two groups. Correlations between PFF, HFF, PPHFI, and BMI z-scores in each group were also analyzed. Results: The PFF, HFF, PPHFI, and BMI z-score were higher in the group with obesity than in the control group (PFF: 6.65±3.42 vs. 1.78±0.55, HFF: 19.5±13.0 vs. 2.31±1, PPHFI: 3.65 ±1.63 vs. 0.94±0.31, BMI z-score: 2.27±0.56 vs. 0.42±0.54, p<0.01, respectively). PFF was correlated with BMI z-scores, PPHFI, and HFF in the obesity group, and multivariate analysis showed that PFF was strongly correlated with BMI z-score and PPHFI (p<0.05). The BMI z-score was strongly correlated with PFF in the control group (p<0.01). Conclusion: These results suggest that MRI-derived PFF measures are associated with childhood obesity. PFF and PPHFI were also highly correlated in the obesity group. Therefore, PFF may be an objective index of pancreatic fat content and has the potential for clinical utility as a non-invasive biomarker for the assessment of childhood obesity.
Abstract
Purpose: The aim of this study was to evaluate the pancreatic fat fraction (PFF) using magnetic resonance imaging (MRI) in children with and without obesity and to correlate PFF with body mass index (BMI) z-score, hepatic fat fraction (HFF), and ultrasonography-derived pancreato-perihepatic fat index (PPHFI). Methods: This prospective study included 45 children with obesity and 19 without obesity (control group). PFF and HFF were quantitatively assessed using the abdominal multi-echo Dixon method for MRI. The PPHFI was assessed using transabdominal ultrasonography. Anthropometric, MRI, and ultrasonographic characteristics were compared between the two groups. Correlations between PFF, HFF, PPHFI, and BMI z-scores in each group were also analyzed. Results: The PFF, HFF, PPHFI, and BMI z-score were higher in the group with obesity than in the control group (PFF: 6.65±3.42 vs. 1.78±0.55, HFF: 19.5±13.0 vs. 2.31±1, PPHFI: 3.65 ±1.63 vs. 0.94±0.31, BMI z-score: 2.27±0.56 vs. 0.42±0.54, p<0.01, respectively). PFF was correlated with BMI z-scores, PPHFI, and HFF in the obesity group, and multivariate analysis showed that PFF was strongly correlated with BMI z-score and PPHFI (p<0.05). The BMI z-score was strongly correlated with PFF in the control group (p<0.01). Conclusion: These results suggest that MRI-derived PFF measures are associated with childhood obesity. PFF and PPHFI were also highly correlated in the obesity group. Therefore, PFF may be an objective index of pancreatic fat content and has the potential for clinical utility as a non-invasive biomarker for the assessment of childhood obesity.
참고문헌 (25)
- Van Name M, "Type 2 diabetes mellitus in pediatrics : a new challenge", World J Pediatr, 9, pp.293~299 (2013)
- Malecka-Tendera E, "Childhood obesity: a pandemic of the twenty-first century", Int J Obes (Lond), 30(Suppl 2), pp.S1~S3 (2006)
- Min-Su Oh, "Associations among the Degree of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, Degree of Obesity in Children, and Parental Obesity", Pediatric Gastroenterology, Hepatology & Nutrition, 19(3), pp.199~206 (2016), 대한소아소화기영양학회
- Maggio AB, "Increased pancreatic fat fraction is present in obese adolescents with metabolic syndrome", J Pediatr Gastroenterol Nutr, 54, pp.720~726 (2012)
- Finucane MM, "National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants", Lancet, 377, pp.557~567 (2011)
- Ou HY, "The association between nonalcoholic fatty pancreas disease and diabetes", PLoS One, 8, pp.e62561~ (2013)
- Catanzaro R, "Exploring the metabolic syndrome : nonalcoholic fatty pancreas disease", World J Gastroenterol, 22, pp.7660~7675 (2016)
- Patel NS, "Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease", Aliment Pharmacol Ther, 37, pp.630~639 (2013)
- Kim SY, "Quantitative assessment of pancreatic fat by using unenhanced CT : pathologic correlation and clinical implications", Radiology, 271, pp.104~112 (2014)
- Choi CW, "Associated factors for a hyperechogenic pancreas on endoscopic ultrasound", World J Gastroenterol, 16, pp.4329~4334 (2010)
- Lee JS, "Clinical implications of fatty pancreas : correlations between fatty pancreas and metabolic syndrome", World J Gastroenterol, 15, pp.1869~1875 (2009)
- Elhady M, "Fatty pancreas in relation to insulin resistance and metabolic syndrome in children with obesity", J Pediatr Endocrinol Metab, 32, pp.19~26 (2009)
- Jeong HT, "Quantitative analysis of pancreatic echogenicity on transabdominal sonography : correlations with metabolic syndrome", J Clin Ultrasound, 43, pp.98~108 (2015)
- Kim DR, "Ultrasonographic quantitative analysis of fatty pancreas in obese children : its correlation with metabolic syndrome and homeostasis model assessment of insulin resistance", J Pediatr, 193, pp.134~138.e1 (2018)
- Schwenzer NF, "Quantification of pancreatic lipomatosis and liver steatosis by MRI : comparison of in", opposed-phase and spectral-spatial excitation techniques, 2008, pp.43, 330~337
- Fishbein MH, "Introduction of fast MR imaging in the assessment of hepatic steatosis", Magn Reson Imaging, 15, pp.287~293 (1997)
- Ogilvie RF, "The islands of langerhans in 19 cases of obesity", J Pathol Bacteriol, 37, pp.473~481 (1983)
- Tushuizen ME, "Pancreatic fat content and beta-cell function in men with and without type 2 diabetes", Diabetes Care, 30, pp.2916~2921 (2007)
- Pezzilli R, "Pancreatic steatosis: is it related to either obesity or diabetes mellitus?", World J Diabetes, 5, pp.415~419 (2014)
- Heni M, "Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and", or impaired glucose tolerance : a nuclear magnetic resonance study, 2010, pp.26, 200~205
- Staaf J, "Pancreatic fat is associated with metabolic syndrome and visceral fat but not beta-cell function or body mass index in pediatric obesity", Pancreas, 46, pp.358~365 (2017)
- Pacifico L, "Pancreatic fat and β-cellfunction in overweight", obese children with nonalcoholic fatty liver disease, 2015, pp.21, 4688~4695
- Sijens PE, "MRI-determined fat content of human liver, pancreas and kidney", World J Gastroenterol, 16, pp.1993~1998 (2010)
- Kinner S, "Quantitative imaging biomarkers of NAFLD", Dig Dis Sci, 61, pp.1337~1347 (2016)
- Sakai NS, "Obesity, metabolic disease and the pancreas-quantitative imaging of pancreatic fat", Br J Radiol, 91, pp.20180267~ (2018)